chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 45 minutes after receiving the vaccine shot, I experienced sudden dizziness and nausea for approximately 1 minute. Also, my entire left arm looked a bit red, but no hives. It went away as quickly as it occurred. Approximately 30 minutes after that, I experienced nausea again( which was a bit more intense). It also lasted for approximately 1 minute then it quickly ceased. At 4pm (5 hours after the shot), I got a severe headache. I'm not sure if that was related to the vaccine. I took acetaminophen and slept soundly through the night. The next day, I felt fine, and I have felt fine since.
A couple days later I started having upper eye twitching on left eye. I'm still having this symptom.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. In 2010, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 09-JUL-2016, the patient was treated by a physician for the onset of severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
12 hours post vax, the pt experienced a 7 x 9 cm erythema and induration.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Head pain, trouble seeing-Severe, Additional Details: Patient was responsive during the event. Mom requested we call 911. Patient did not exhibit any allergy symptoms. Pulse normal
Chills and body ache for 18 hours since symptoms started.   Low energy and fatigue since the day after the second dose of  vaccine.  Dizziness, stomach ache 10 days  after the vaccine. A mont later after the vaccine (3/30) I had headache, body ache and chills for 6 days.  COVID test was negative  Palpitations started on 4/4. Dizziness, chills, dry eyes, weakness and fatigue until today.
Initial report received from a healthcare professional on 14 December 2012. A female patient, whose medical history and concomitant medications were not reported, had received an intramuscular dose of ADACEL (Lot number: U4421AA, dose number not reported) in right deltoid on an unspecified date. The patient was pregnant. The last menstrual period date was not reported. The estimated date of delivery is 09 January 2013. The patient's health during pregnancy, medical history, concomitant medications and risk factors were not reported. As of 14 December 2012, the patient did not experience any adverse event. Follow-up information received from a health care professional on 03 September 2013. The patient maternal age was 32 years. The patient last menstrual period was 09 April 2012. The patient experienced IUGR, HTN, thrombocytopenia on unreported dates during pregnancy. The patient was administered Tdap, flu, manufacturer not reported, RHOGAM and SUBOXONE during pregnancy on unreported dates. The patient did not experience any adverse events following vaccination. The mother's pregnancy history was one pregnancy with a normal outcome. The end of pregnancy date was 20 December 2012. The birth outcome was infant normal. Documents held by sender: None.
She also had congestion in nasal passages, and sore throat on and off after all vaccinations; She also had congestion in nasal passages, and sore throat on and off after all vaccinations; This spontaneous case was reported by a patient and describes the occurrence of NASAL CONGESTION (She also had congestion in nasal passages, and sore throat on and off after all vaccinations) and OROPHARYNGEAL PAIN (She also had congestion in nasal passages, and sore throat on and off after all vaccinations) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Lupus erythematosus (Lupus in 1975 secondary to Tetracycline (Went away by d/c of tetracycline)) in 1975. Previously administered products included for Drug use for unknown indication: Tetracycline in 1975. Past adverse reactions to the above products included Lupus erythematosus with Tetracycline. Concurrent medical conditions included Lyme disease since 2013 and Hypothyroidism. Concomitant products included THYROID (ARMOUR THYROID) for Hypothyroidism.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced NASAL CONGESTION (She also had congestion in nasal passages, and sore throat on and off after all vaccinations) and OROPHARYNGEAL PAIN (She also had congestion in nasal passages, and sore throat on and off after all vaccinations). At the time of the report, NASAL CONGESTION (She also had congestion in nasal passages, and sore throat on and off after all vaccinations) and OROPHARYNGEAL PAIN (She also had congestion in nasal passages, and sore throat on and off after all vaccinations) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: had 2 Negative Lyme Disease tests before and after vaccination.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated that she had congestion in nasal passages, and sore throat on and off after all vaccinations and in between. She thinks she has Mold around her home that may be causing it. She states that this issue did not exist prior to Pandemic and vaccinations. No treatment medications were reported.   This case was linked to MOD-2022-647550 (Patient Link).
This spontaneous report as received from medical assistant via company representative refers to a 53 year old female patient with no pertinent medical history and no drug reactions or allergies. On 11-OCT-2013, the patient was vaccinated with first dose of ZOSTAVAX lot # J002692 exp. date 30-APR-2014 (dose and route not reported). There was no concomitant medication. On an approximately 11-OCT-2013, within 24 hours (exact time to onset unspecified), the patient noted pain, swelling, and hardness at the injection site. The area was also warm to the touch and had a bright erythema the size of an egg surrounding it. Today (14-OCT-2013) the erythema was larger and there was a blistering rash. However, the pain, swelling, hardness, warmth have all lessened. It was also reported that the patient's outcome was not recovered. There was no treatment given for the patient's events. No lab diagnostics studies were performed. It was reported that the patient called the office in regards to events. Causality was not provided. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of Bell's palsy in a 79-year-old patient who received Shingrix for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix about 4 months ago). On 7th August 2018, the patient received the 2nd dose of Shingrix. On 7th August 2018, less than a day after receiving Shingrix, the patient experienced Bell's palsy (serious criteria GSK medically significant), pain in arm, runny nose, eye pain and eyes tearing. On 8th August 2018, the patient experienced ptosis. On an unknown date, the outcome of the Bell's palsy, ptosis, runny nose, eye pain and eyes tearing were recovering/resolving and the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the bell's palsy, pain in arm, ptosis, runny nose, eye pain and eyes tearing to be related to Shingrix. Additional details were provided as follows: The patient received 1st dose of Shingrix 4 months before the reporting date and experienced no side effects. After 2nd dose vaccination, the patient experienced a sore arm that hurt and had a runny nose. Just before he went to bed, he experienced both his eyes hurting and tearing up. The next morning, his wife noted that he his left eye was drooping, and thought he had a stroke.  The patient went to the emergency room and was diagnosed with Bell's Palsy. The patient also had a CT scan which was negative. The patient was discharged from emergency the same day. At the time of report, the patient was noticing an improvement in his Bell's Palsy symptoms. The contact details of the physician was provided, phone number was not available but was okay to send patient letter.
Chills; Headache; Low graded fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Low graded fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Low graded fever). On 03-Jan-2021, CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Low graded fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication for event included acetaminophen.
pt recvd vax 2DEC94 & 5hrs later vomited large amount of emesis;given APAP;fed new formula;later,went pale & limp;appearing as in shock;stopped breathing @ 1min(2 episodes);MD states hospitalized 4 days;placed on apnea monitor;pt recovered
8 days after dose 1 of the Moderna vaccine, I developed a red, hot, spot about 6 inches in diameter around the injection site.  It was a delayed onset.
Burning skin sensation, all over body lasted about 6 hours; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Apr2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes (diabetic). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included insulin (MANUFACTURER UNKNOWN) since an unknown date, for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.   On an unknown date in Apr2021, the patient experienced burning skin sensation, all over body which lasted about 6 hours. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event burning skin sensation, all over body lasted about 6 hours was recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Starting late May (around two weeks after second dose), I developed noticeably blurrier vision in my right eye. Over time that developed into double vision and blurry vision in both eyes that persists to this day. It comes and goes and has improved somewhat over the last few weeks but my vision is definitely not back to 20/20.
Child had difficulty breathing slept for 12-18 hrs not drinking well. Baby was drowsy, tachypneic, not drinking well but lungs clear. Dx ? reaction to hep B? early viral infection.
This spontaneous report as received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 06-JUN-2012, patient received improperly stored (Oka/Merck) VARIVAX dose 2, from batch/lot # 671861/1907AA (expiry date, dose units, route and anatomical location were not specified) (incorrect product storage). Concomitant medication were not reported. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received form the same reporter. Additional information has been requested.
Shingles rash on right thigh- two areas in L-2 dermotome
Slight pain/discomfort; Redness at injection site on left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration on 20Feb2021 in the left arm (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Feb2021 the patient experienced slight pain/discomfort and redness at injection site on left arm. The events did not result in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight pain/discomfort and redness at injection site on left arm was recovered on an unknown date. No follow-up attempts are possible. No further information is expected.
Patient received Moderna dose #1 on 8/4/21 and dose #2 on 9/1/21. Upon entering this into database, It was documented that she had received Pfizer vaccine in Feb 2021 and Johnson & Johnson vaccine in May 2021. In packet that we receive upon admission, stated did not receive any Covid-19 vaccinations.
Developed rash on chest and arms  - 4 days after vaccine. I had the same rash 11 days after injection #2, but attributed that rash to a skin contact allergy (medical adhesive).  In retrospect, the rash after the 2nd dose (2/5/2021) is now attributed to the Covid Moderna Vaccine as well
Developed rash 10/7/15. Had varicella vaccine 9/22/15.
High fever, severe muscle aches, severe headaches located in the back of her head, migraines, vision problems with grid-like vision, nausea and diarrhea with lose of 6 pounds and dizziness
Patient received 3rd dose of HPV-9 vaccine in the morning on 23 Aug 2021 approximately 5 hours later patient returned to clinic with redness, swelling, pain, decreased ROM in right arm and low grade temp 99.2. Patient was given an ice pack, diagnosed with cellulitis, given clindamycin 300mg 1 cap daily for 10 days, and tylenol and benadryl for pain and swelling. On 26 Aug, follow-up, patient was given Percocet 5-325mg 1 tab q4h PRN severe pain #30. On 21 Sep 2021, patient began physical therapy. Patient's most recent follow up appointment occurred 9 Dec; patient still having symptoms during exercise and will continue to work with PT to strengthen.
Local reaction, 24 hours after vaccine given, 7 x 3.5cm in size, redness, mild swelling.
Member got first COVID Vaccine and report to ER with "Kidney Pain". Member received second COVID Vaccine and was diagnosis with MONO. Pt was informed that COVID Vaccine can reactive Mono. Pt had mono in the past.
severe pain at injection site, since that time has started blacking out, seizures, migraines, heart palpitations, blood pressure control problems, nausea, severe pain in extremities, tingling in arms and legs,severe tiredness, low quality of life. 11/4/09 Medical records received for date 6/5/08 to 10/28/09. 6/5/08 Pt established care at PCP with initial c/o multiple syncopal episodes in past few wks. Mostly when changing positions lying/sitting. DX: syncope, irreg. menses, sinusitis, insomnia. Multiple OV for c/o syncope, body aches, dizziness, chest pain, ear pain, DX: syncopal episodes, orthostatic HTN, muscle pain, chest pain, tachycardia, depression/anxiety, autonomic dysfunction.
Patient passed out for a few seconds shortly after getting immunization. I put an ice pack on his neck and had him rest for about 15 minutes before walking.
Starting at 4pm, complained about leg.  When she tried to walk, she had a severe limp.  Quickly developed a fever of 100.1.  Gave cool bath with Epsom salts and ibuprofen.  At 1am, she vomited and her fever had increased to 102.   Gave her Tylenol.  She was coughing regularly all night.  Fever and coughing has continued throughout the next day (2/16/16).
left arm under injection site is burning, itchy and has a hive forming; left arm under injection site is burning, itchy and has a hive forming; left arm under injection site is burning, itchy and has a hive forming; fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (left arm under injection site is burning, itchy and has a hive forming), VACCINATION SITE URTICARIA (left arm under injection site is burning, itchy and has a hive forming), INJECTION SITE PAIN (left arm under injection site is burning, itchy and has a hive forming) and PYREXIA (fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced INJECTION SITE PRURITUS (left arm under injection site is burning, itchy and has a hive forming), VACCINATION SITE URTICARIA (left arm under injection site is burning, itchy and has a hive forming) and INJECTION SITE PAIN (left arm under injection site is burning, itchy and has a hive forming). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PRURITUS (left arm under injection site is burning, itchy and has a hive forming), VACCINATION SITE URTICARIA (left arm under injection site is burning, itchy and has a hive forming), INJECTION SITE PAIN (left arm under injection site is burning, itchy and has a hive forming) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       .
Information has been received from a physician concerning a 14 year old female patient who in April 1996, was vaccinated with the first dose of MMR II. On 01-SEP-1999, the patient received the second dose of MMR II. On 29-DEC2009, the patient experienced mumps (date of diagnosed was reported to be on 25-DEC-2009). The patient was afebrile and had parotitis. The outcome of the patient was not reported. Follow up information has been received reporting that on 22-NOV-2009 (previously reported as 25-DEC-2009) the patient experienced mumps. Mumps was diagnosed on 23-NOV-2009 (previously reported as 25-DEC-2009). The patient developed a sore throat and left parotitis. On 23-NOV-2009 the first blood work was performed, the results were: IgM (<1:10) : <1:10, IgG (>1.10): 7.11 and serum amylase: 381. At the time of the report, the patient's outcome was unknown. This is one of several cases from the same source. Additional information has been requested.
Fainted and fell on the floor; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SYNCOPE (Fainted and fell on the floor) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, the patient experienced SYNCOPE (Fainted and fell on the floor) (seriousness criteria hospitalization and medically significant). The patient was hospitalized for 2 days due to SYNCOPE. At the time of the report, SYNCOPE (Fainted and fell on the floor) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines were reported. Treatment information included heart monitoring and head scan.  Company Comment:. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Urine flow/slowed to a painful drip. Urination became incredibly difficult; Urine flow/slowed to a painful drip. Urination became incredibly difficult; Dose number=3; This is a spontaneous report received from a contactable Other HCP. The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 20Dec2021 15:00 (Lot number: 33025BD) at the age of 60 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Possible prostate hypertrophy" (unspecified if ongoing). Concomitant medication(s) included: TAMSULOSIN; CEFUROXIME. Vaccination history included: Bnt162b2 (dose number=2, product=COVID 19, brand=Pfizer, lot number=EW0151, administration date=14Apr2021, administration time=05:15 PM, vaccine location=Right arm), administration date: 14Apr2021, when the patient was 59 years old, for Covid-19 Immunization; Bnt162b2 (product=COVID 19, brand=Pfizer , lot number=EN6207, administration date=22Mar2021, administration time=06:00 PM, dose number=1, vaccine location=Right arm), administration date: 22Mar2021, when the patient was 59 years old, for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 20Dec2021 15:00, outcome "unknown", described as "Dose number=3"; URINE FLOW DECREASED (non-serious), DYSURIA (non-serious) all with onset 20Dec2021 19:00, outcome "recovered" (Dec2021) and all described as "Urine flow/slowed to a painful drip. Urination became incredibly difficult". The event "urine flow/slowed to a painful drip. urination became incredibly difficult" and "urine flow/slowed to a painful drip. urination became incredibly difficult" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of urine flow decreased, dysuria.  Additional information: The patient did not receive any other vaccine in four weeks. The patient did not had COVID prior vaccination and post vaccination, patient had not tested with COVID-19. Within 4-6 hours post vaccine, urine flow, which had been improving slowed to a painful drip. Urination became incredibly difficult over the next 36hrs and then it began to improve.  No follow-up attempts are possible. No further information is expected.
A high fever at night with a seizure activity. After the two-month vaccination, patient started to have partial seizures without notable reasons
My period was 2 weeks late after the first dose and now with 2 dose i just got  my period 10 days after my last one. So this is my 2nd period within the last 2 weeks . This has never happened to me.
12 hours after vaccination:  nausea with vomit, severe chills 15 hours after vaccination:  low grade fever began 22 to 36 hours after vaccination:  low grade fever, achy muscles, mild nausea, fatigue 36 hours after vaccination:  return to normal